3TON | pdb_00003ton

Crystral Structure of the C-terminal Subunit of Human Maltase-Glucoamylase


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.95 Å
  • R-Value Free: 
    0.288 (Depositor), 0.282 (DCC) 
  • R-Value Work: 
    0.232 (Depositor), 0.228 (DCC) 
  • R-Value Observed: 
    0.235 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 3TON

This is version 1.2 of the entry. See complete history

Literature

Structural insight into substrate specificity of human intestinal maltase-glucoamylase

Ren, L.M.Qin, X.H.Cao, X.F.Wang, L.L.Bai, F.Bai, G.Shen, Y.

(2011) Protein Cell 2: 827-836

  • DOI: https://doi.org/10.1007/s13238-011-1105-3
  • Primary Citation Related Structures: 
    3TON, 3TOP

  • PubMed Abstract: 

    Human maltase-glucoamylase (MGAM) hydrolyzes linear alpha-1,4-linked oligosaccharide substrates, playing a crucial role in the production of glucose in the human lumen and acting as an efficient drug target for type 2 diabetes and obesity. The amino- and carboxyl-terminal portions of MGAM (MGAM-N and MGAM-C) carry out the same catalytic reaction but have different substrate specificities. In this study, we report crystal structures of MGAM-C alone at a resolution of 3.1 Å, and in complex with its inhibitor acarbose at a resolution of 2.9 Å. Structural studies, combined with biochemical analysis, revealed that a segment of 21 amino acids in the active site of MGAM-C forms additional sugar subsites (+ 2 and + 3 subsites), accounting for the preference for longer substrates of MAGM-C compared with that of MGAM-N. Moreover, we discovered that a single mutation of Trp1251 to tyrosine in MGAM-C imparts a novel catalytic ability to digest branched alpha-1,6-linked oligosaccharides. These results provide important information for understanding the substrate specificity of alpha-glucosidases during the process of terminal starch digestion, and for designing more efficient drugs to control type 2 diabetes or obesity.


  • Organizational Affiliation
    • State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.

Macromolecule Content 

  • Total Structure Weight: 207.45 kDa 
  • Atom Count: 14,270 
  • Modeled Residue Count: 1,780 
  • Deposited Residue Count: 1,816 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Maltase-glucoamylase, intestinal
A, B
908Homo sapiensMutation(s): 0 
Gene Names: MGAM
EC: 3.2.1.20 (PDB Primary Data), 3.2.1.3 (PDB Primary Data)
UniProt & NIH Common Fund Data Resources
Find proteins for O43451 (Homo sapiens)
Explore O43451 
Go to UniProtKB:  O43451
PHAROS:  O43451
GTEx:  ENSG00000257335 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO43451
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.95 Å
  • R-Value Free:  0.288 (Depositor), 0.282 (DCC) 
  • R-Value Work:  0.232 (Depositor), 0.228 (DCC) 
  • R-Value Observed: 0.235 (Depositor) 
Space Group: P 43 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 106.232α = 90
b = 106.232β = 90
c = 517.557γ = 90
Software Package:
Software NamePurpose
HKL-2000data collection
PHASESphasing
PHENIXrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2011-11-23
    Type: Initial release
  • Version 1.1: 2023-11-01
    Changes: Data collection, Database references, Refinement description
  • Version 1.2: 2024-11-06
    Changes: Structure summary